rituximabBelimumabcyclophosphamideBLMbDMARDcDMARDSLEsystemic lupus erythematosus
…s received BLM after bDMARD. The main bDMARD use before BLM was rituximab in the 85.3% of patients. Baseline characteristics are summariz…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: cDMARD ×
cDMARD
This drug is selected. Its supporting articles are shown below.